Next Article in Journal
Quorum Sensing Inhibitors from Marine Microorganisms and Their Synthetic Derivatives
Next Article in Special Issue
Deciphering Molecular Mechanism of the Neuropharmacological Action of Fucosterol through Integrated System Pharmacology and In Silico Analysis
Previous Article in Journal
Preparation and Characterization of Gelatin and Antioxidant Peptides from Gelatin Hydrolysate of Skipjack Tuna (Katsuwonus pelamis) Bone Stimulated by in vitro Gastrointestinal Digestion
Previous Article in Special Issue
Anti-Neuroinflammatory Property of Phlorotannins from Ecklonia cava on Aβ25-35-Induced Damage in PC12 Cells
Article

Testing the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay

Division of Life Science, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China
*
Author to whom correspondence should be addressed.
Mar. Drugs 2019, 17(2), 79; https://doi.org/10.3390/md17020079
Received: 23 December 2018 / Revised: 20 January 2019 / Accepted: 21 January 2019 / Published: 24 January 2019
Cell cycle reentry is a unified mechanism shared by several neurodegenerative diseases, including Alzheimer’s disease (AD) and Ataxia Telangiectasia (A-T). This phenotype is often related to neuroinflammation in the central nervous system. To mimic brain inflammation in vitro, we adopted the previously established method of using conditioned medium collected from activated THP-1 cells and applied it to both differentiated HT22 cells and primary neurons. Unscheduled cell cycle events were observed in both systems, indicating the potential of this approach as an in vitro model of neurodegenerative disease. We used this assay to measure the neuroprotective effects of New Zealand green-lipped mussel extract, PCSO-524®, to protect post-mitotic cells from cell cycle reentry. We found that, both in vitro and in an animal model, PCSO-524® displayed promising neuroprotective effects, and thus has potential to postpone or prevent the onset of neurodegenerative disease. View Full-Text
Keywords: PCSO-524®; neuroinflammation; neuronal cell cycle event; neuroprotection; Alzheimer’s disease PCSO-524®; neuroinflammation; neuronal cell cycle event; neuroprotection; Alzheimer’s disease
Show Figures

Figure 1

MDPI and ACS Style

Zhu, B.; Zhang, Y.; Herrup, K. Testing the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay. Mar. Drugs 2019, 17, 79. https://doi.org/10.3390/md17020079

AMA Style

Zhu B, Zhang Y, Herrup K. Testing the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay. Marine Drugs. 2019; 17(2):79. https://doi.org/10.3390/md17020079

Chicago/Turabian Style

Zhu, Beika, Yang Zhang, and Karl Herrup. 2019. "Testing the Neuroprotective Properties of PCSO-524® Using a Neuronal Cell Cycle Suppression Assay" Marine Drugs 17, no. 2: 79. https://doi.org/10.3390/md17020079

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop